NCT03300947: Psilocybin for Treatment of Obsessive Compulsive Disorder
- State
- Completed
- Phase
- Phase 1
- People
- 15 taking part
- Started
- 2 Jan 2019
- Primary completion
- 30 Oct 2023
- Arms
- High- or Low-dose Psilocybin
- Results
- None posted
- Papers
- doi:10.1177/02698811261424214, doi:10.4088/jcp.v67n1110
- 4 Oct 2017: Trial registered
- 2 Jan 2019: Trial started
- 30 Dec 2023: Trial completed